Overview

Alpha Preclinical is a leader in gene therapy research, offering specialized services to support the development of innovative treatments. With over a decade of experience in nucleic acid administration and vector systems, we provide tailored solutions to advance your gene therapy programs.

Why Choose Our Gene Therapy Services?

• Deep Expertise: Our scientists have extensive experience with multiple carrier/vector systems and routes of administration.

• Customized Study Designs: We develop gene therapy protocols tailored to your specific therapeutic goals, ensuring translational relevance.

• Rapid Study Execution: Initiate studies within approximately three weeks to keep your research on track.

• Comprehensive Support: From study design to data interpretation, we partner with you to achieve successful outcomes.

Applications

• Gene replacement therapy for genetic disorders

• Nucleic acid delivery for oncology, autoimmune, or metabolic diseases

• Development of viral and non-viral vector systems

• Preclinical testing for regulatory submissions

Our Process

1. Study Planning: Collaborate with our team to design gene therapy studies aligned with your research objectives.

2. Execution: Conduct experiments using advanced vector systems and administration methods in our North Grafton, MA facility.

3. Data Reporting: Receive comprehensive reports with detailed analyses to support your program’s advancement.

4. Ongoing Partnership: Benefit from transparent communication and strategic guidance throughout your project.

Get Started

Accelerate your gene therapy research with Alpha Preclinical’s expert services.